Published in Obstet Gynecol on November 01, 2009
Using data to effectively manage a national screening program. Cancer (2014) 1.14
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control (2015) 0.79
Quantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasia. Clin Epigenetics (2015) 0.75
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol (2013) 5.40
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
Recent trends in U.S. mammography use from 2000-2006: a population-based analysis. Prev Med (2008) 3.22
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis (2013) 3.06
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
Breast cancer as a global health concern. Cancer Epidemiol (2009) 2.71
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ (2012) 2.57
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 1.95
Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health (2009) 1.90
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. J Low Genit Tract Dis (2015) 1.73
The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr (2006) 1.71
Developing and testing a cost-assessment tool for cancer screening programs. Am J Prev Med (2009) 1.67
Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control (2006) 1.64
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine (2012) 1.61
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol (2011) 1.51
Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years. Cancer (2009) 1.50
Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050. Cancer Epidemiol (2010) 1.49
The cost-effectiveness of male HPV vaccination in the United States. Vaccine (2011) 1.48
Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol (2005) 1.44
Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol (2011) 1.44
Economic burden of cancer survivorship among adults in the United States. J Clin Oncol (2013) 1.41
Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics (2011) 1.41
Lung cancer incidence trends among men and women--United States, 2005-2009. MMWR Morb Mortal Wkly Rep (2014) 1.35
Cost-effectiveness of human papillomavirus vaccination in the United States. Emerg Infect Dis (2008) 1.35
The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv (2012) 1.31
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol (2015) 1.30
Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004. Cancer (2008) 1.26
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev Med (2013) 1.22
Cervical cancer screening among young adult women in the United States. Cancer Epidemiol Biomarkers Prev (2013) 1.22
Physician recommendation for papanicolaou testing among U.S. women, 2000. Cancer Epidemiol Biomarkers Prev (2005) 1.22
Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012. MMWR Morb Mortal Wkly Rep (2014) 1.21
Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med (2011) 1.21
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep (2014) 1.18
When performance management works: a study of the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 1.18
Trends in endometrial cancer incidence rates in the United States, 1999-2006. J Womens Health (Larchmt) (2011) 1.17
Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.16
On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol (2007) 1.14
Using data to effectively manage a national screening program. Cancer (2014) 1.14
Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty. Health Serv Res (2008) 1.13
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol (2010) 1.12
Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer (2011) 1.12
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev (2013) 1.08
State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care (2012) 1.06
Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol (2004) 1.05
Mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates. AJR Am J Roentgenol (2009) 1.05
2013 Vulvodynia Guideline update. J Low Genit Tract Dis (2014) 1.04
Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2005) 1.04
From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 1.02
Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut (2011) 1.02
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer (2008) 1.02
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 1.01
Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. J Low Genit Tract Dis (2008) 1.01
Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care. Womens Health Issues (2010) 1.00
Public health national approach to reducing breast and cervical cancer disparities. Cancer (2014) 0.99
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int (2011) 0.98
Impact of the 2002 American society for Colposcopy and Cervical Pathology guidelines on cervical cancer diagnosis in a geographically diverse population of commercially insured women, 1999-2004. J Low Genit Tract Dis (2011) 0.97
National Breast and Cervical Cancer Early Detection Program data validation project. Cancer (2014) 0.96
Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program. Eval Program Plann (2008) 0.96
Timing of colposcopy after cervical cytologic abnormalities. Obstet Gynecol (2010) 0.95
Characteristics of US counties with no mammography capacity. J Community Health (2012) 0.94
Access to preventive health care for cancer survivors. Am J Prev Med (2013) 0.94
Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening. J Womens Health (Larchmt) (2013) 0.93
Melanoma treatment costs: a systematic review of the literature, 1990-2011. Am J Prev Med (2012) 0.93
The impact of a national program to provide free mammograms to low-income, uninsured women on breast cancer mortality rates. Cancer (2010) 0.92
Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Manag Sci (2013) 0.92
Years of potential life lost and productivity losses from male urogenital cancer deaths--United States, 2004. Urology (2010) 0.90
Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer (2013) 0.88
Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women. Med Care (2011) 0.87
The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer. Health Econ (2009) 0.87
Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care (2014) 0.86
Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States. Vaccine (2013) 0.86
A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program. Cancer Causes Control (2015) 0.86
Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States. Am J Manag Care (2010) 0.86
US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. Sex Health (2010) 0.85
Enhancing cancer registry data for comparative effectiveness research (CER) project: overview and methodology. J Registry Manag (2014) 0.84
Breast cancer mortality among American Indian and Alaska Native women, 1990-2009. Am J Public Health (2014) 0.82
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. Int J Gen Med (2011) 0.81
Cost of services provided by the National Breast and Cervical Cancer Early Detection Program. Cancer (2014) 0.80
News from the CDC: collaborations to build capacity at the community level in cancer prevention and control. Transl Behav Med (2013) 0.80
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences. J Sex Med (2013) 0.79
The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States. Sex Transm Dis (2014) 0.79